[Relationship of mdr1 gene expression and multidrug resistance of primary lung cancer]. 1997

L Bai, and Y Sun, and S Li
Department of Medical Oncology, Chinese Academy of Medical Science, Beijing.

OBJECTIVE To evaluate the expression of mdr1 gene in various type of primary lung cancer. METHODS A serious of 48 resected primary lung cancer tissues from 5 post-chemotherapy and 43 untreated patients and 33 adjacent normal lung tissues were analyzed for mdr1 gene by RT-PCR method. RESULTS Fifteen of 48 tumor tissues were found to have overexpression of mdr1 gene, comprising 6 of 12 adenocarcinomas, 7 of 22 squamous cell carcinomas, 1 of 2 sarcocarcinomas, 1 of 12 small cell carcinomas. Of 5 post-chemotherapy specimens, only one case showed positive. In addition, 3 of 33 adjacent normal tissues also showed mdr1-positive. Overexpression of mdr1 gene did not be associated with tumor size, metastasis and stage of lung cancer. The relapse rate with mdr1-positive cases was higher (80%) than that with mdr1-negative (58%) by one year follow-up of these patients. CONCLUSIONS Overexpression of mdr1 gene can be detected in untreated primary lung cancer, specially in non-small cell lung cancer and may be regarded as one poorly prognostic marker.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas

Related Publications

L Bai, and Y Sun, and S Li
June 1993, Journal of hepatology,
L Bai, and Y Sun, and S Li
May 1994, Japanese journal of cancer research : Gann,
L Bai, and Y Sun, and S Li
January 1994, In vivo (Athens, Greece),
L Bai, and Y Sun, and S Li
January 1992, Anticancer research,
L Bai, and Y Sun, and S Li
January 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
L Bai, and Y Sun, and S Li
October 1988, Gan to kagaku ryoho. Cancer & chemotherapy,
L Bai, and Y Sun, and S Li
August 2009, Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale,
L Bai, and Y Sun, and S Li
December 1991, Journal of neurosurgery,
L Bai, and Y Sun, and S Li
December 1994, International journal of oncology,
Copied contents to your clipboard!